Prediction of Crohn's disease relapse with faecal calprotectin in infliximab responders: a prospective study.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 78
- By:
- Publication type:
- Article
Works matching IS 14667401 AND DT 2011 AND VI 12 AND IP 2
Results: 32
1
2
Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 79
- By:
- Publication type:
- Article
3
IL-23-responsive innate lymphoid cells are increased in inflammatory bowel disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 74
- By:
- Publication type:
- Article
4
Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 76
- By:
- Publication type:
- Article
5
Clinical features, treatment, and survival of patients with colorectal cancer with or without inflammatory bowel disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 75
- By:
- Publication type:
- Article
6
EVENTS 2012.
- Published in:
- 2011
- Publication type:
- Calendar
7
1st British Society of Gastroenterology Supraregional Meeting Challenges in Gastroenterology & Workshop: Intestinal Inflammation.
- Published in:
- 2011
- By:
- Publication type:
- Proceeding
8
Inflammatory bowel disease in pregnancy.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 80
- By:
- Publication type:
- Article
9
Vaccination and screening for infections in patients with inflammatory bowel disease: a survey of Australian gastroenterologists.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 80
- By:
- Publication type:
- Article
10
Identification of disease-associated DNA methylation in intestinal tissues from patients with inflammatory bowel disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 79
- By:
- Publication type:
- Article
11
The Nod2 sensor promotes intestinal pathogen eradication via the chemokine CCL2-dependent recruitment of inflammatory monocytes.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 75
- By:
- Publication type:
- Article
12
Fecal calprotectin is a useful marker for disease activity in pediatric patients with inflammatory bowel disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 78
- By:
- Publication type:
- Article
13
Screening for cervical and breast cancer among women with inflammatory bowel disease: a population-based study.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 77
- By:
- Publication type:
- Article
14
Outcomes of patients with Crohn's disease improved from 1988 to 2008 and were associated with increased specialist care.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 76
- By:
- Publication type:
- Article
15
Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 73
- By:
- Publication type:
- Article
16
TLR Signalling augments macrophage bactericidal activity through mitochondrial ROS.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 73
- By:
- Publication type:
- Article
17
Pathophysiology of dermatitis herpetiformis: a model for cutaneous manifestations of gastrointestinal inflammation.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 72
- By:
- Publication type:
- Article
18
Role of eosinophils in inflammatory bowel and gastrointestinal diseases.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 72
- By:
- Publication type:
- Article
19
Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 71
- By:
- Publication type:
- Article
20
Epigenetics: principles and practice.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 71
- By:
- Publication type:
- Article
21
Therapy with the opioid antagonist naltrexone promotes muscosal healing in active Crohn's disease: a randomized placebo-controlled trial.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 70
- By:
- Publication type:
- Article
22
Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 69
- By:
- Publication type:
- Article
23
The mucosal addressin cell adhesion molecule antibody PF-00547,659 in ulcerative colitis: a randomised study.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 70
- By:
- Publication type:
- Article
24
Combined azithromycin and metronidazole therapy is effective in inducing remission in pediatric Crohn's disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 68
- By:
- Publication type:
- Article
25
The efficacy of exclusive nutritional therapy in paediatric Crohn's disease, comparing fractionated oral versus continuous enteral feeding.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 68
- By:
- Publication type:
- Article
26
Does adjuvant antibiotic treatment after drainage of anorectal abscess prevent development of anal fistulas? A randomized, placebo-controlled, double-blind, multicenter study.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 67
- By:
- Publication type:
- Article
27
Adverse events of thiopurine immunomodulators in patients with inflammatory bowel disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 67
- By:
- Publication type:
- Article
28
Metabolomics and IBD.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 58
- By:
- Publication type:
- Article
29
IBD Medication Use in Pregnancy: A Review of Evidence For and Against.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 47
- By:
- Publication type:
- Article
30
Severe infusion reactions to infliximab: aetiology, immunogenicity and risk factors in patients with inflammatory bowel disease.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 66
- By:
- Publication type:
- Article
31
Pregnancy and Anti-TNF Use: Safety is Not Yet Assured.
- Published in:
- 2011
- By:
- Publication type:
- Opinion
32
Editorial.
- Published in:
- Inflammatory Bowel Disease Monitor, 2011, v. 12, n. 2, p. 47
- By:
- Publication type:
- Article